GlassScriptPhysician profile
Kayla M Schaefer
NPI 1891317368
$5,670.61
in general payments reported to CMS, 2019-2025
20 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,680 · 2024: $761 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,760 · Travel and Lodging: $1,866 · Education: $44.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,759.72 |
| Travel and Lodging | $1,866.26 |
| Education | $44.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,132.92 | 2023-2025 | Truelok, Physio-Stim |
| Stryker Corporation | $1,340.52 | 2023-2025 | Prostep, Variax, Citrefix |
| Integra Lifesciences Corporation | $481.09 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $332.74 | 2024-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Bioventus LLC | $271.23 | 2023-2025 | Exogen Ultrasound Bone Healing System, Other, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $165.56 | 2023-2025 | |
| Organogenesis INC. | $158.33 | 2025 | Puraply Wound Matrix |
| Medtronic, INC. | $141.10 | 2025 | Hawkone |
| Horizon Therapeutics Plc | $123.50 | 2023 | Krystexxa |
| Nevro Corp. | $117.61 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $107.51 | 2023-2025 | Nuzyra |
| Biotissue Holdings INC. | $103.06 | 2023 | |
| Convatec INC. | $37.34 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $32.15 | 2024 | Magellan |
| Kerecis Limited | $31.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.76 | 2024-2025 | Krystexxa |
| Averitas Pharma INC. | $19.34 | 2025 | Qutenza |
| Checkpoint Surgical, INC | $16.34 | 2023 | Checkpoint Stimulators |
| Ani Pharmaceuticals, INC. | $15.32 | 2024 | Purified Cortrophin Gel |
| Mimedx Group, INC. | $13.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.